COVID-19-Associated Encephalitis, Long COVID
Conditions
Keywords
pediatric neurology, psychiatric evaluation, Long COVID syndrome, magnetic resonance image
Brief summary
We enroll pediatric patients who were diagnosed COVID-19 for main observation target. We will perform brain MRI and neuropsychiatric evaluation 4-6 months after COVID-19 diagnosed. We also enroll healthy age- and gender-matched participant for cross-over comparison. We will perform same evaluation process one year later for longitudinal evaluation
Interventions
Brain MRI including diffusion spectrum image, and functional MRI Interview with questionnaires for neuropsychiatric evaluation Near infrared spectroscopy and resting-state connectivity evaluation
Sponsors
Study design
Eligibility
Inclusion criteria
* Age 6-18 years old * Has been diagnosed COVID-19 before
Exclusion criteria
* History of neuropsychiatric disorders * Have some device not allowed for MRI
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Difference between COVID and healthy group | 1 years after enrollment for primary evaluation | The neuroimage difference between COVID and healthy group and the correlation with neuropsychiatric evaluation |
Countries
Taiwan